2B92.1

ICD-11 MMS 2026-01

Neuroendocrine neoplasms of rectum

Description

Malignant neoplasms with neuroendocrine differentiation that arise in the rectum. Most are well differentiated neuroendocrine tumours (low and intermediate grade), i.e. carcinoids. Poorly differentiated neuroendocrine carcinomas (high grade) are rare.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Neuroendocrine neoplasms of rectum
  • Neuroendocrine tumour of rectum
  • Neuroendocrine carcinoma of rectum
Show allHide
  • Rectal neuroendocrine neoplasm
  • Rectal endocrine neoplasm
  • Rectal neuroendocrine tumour
  • Other specified neuroendocrine neoplasm of rectum

Exclusions from above levels

  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/111033337 – Malignant neoplasm metastasis in digestive system
  • http://id.who.int/icd/entity/794095161 – Malignant neoplasms of lip, oral cavity or pharynx
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B92.0 – Adenocarcinomas of rectum
  • 2B92.Y – Other specified malignant neoplasms of rectum
  • 2B92.Z – Malignant neoplasms of rectum, unspecified

Foundation entity

Neuroendocrine neoplasms of rectum – http://id.who.int/icd/entity/1721143857

Allowed postcoordination axes

Part of: 2B92: Malignant neoplasms of rectum › 02: Neoplasms